Additionally, we performed a bioinformatics analysis of JARID1B expression profiles from 876 GC patients using the Kaplan–Meier method and found that high expression of JARID1B was significantly correlated with poorer overall survival, first progression survival, and post-progression survival of GC patients (Figures 1C–E). The gene discussed is KDM5B; the disease is gastric cancer.